Novartis Venture Fund key facts
- Novartis Venture Fund is a other based in Basel, Switzerland with 23 tracked portfolio companies.
- Notable positions include Binx, Artios, Mediar Therapeutics.
About Novartis Venture Fund
Novartis Venture Fund is a direct investment firm based in Basel, Switzerland. Established in 1996, the firm prefers to invest in the life sciences, oncology, biotechnology, and digital health sectors. The assets are managed by the executive management team.
Novartis Venture Fund portfolio at a glance
23 portfolio companies are on record for Novartis Venture Fund, including Binx, Artios and Mediar Therapeutics.
14 of the 23 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 23 recorded positions
- ·Watchlist + alerts for Novartis Venture Fund's activity
Portfolio
23 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Binx | — | ▮ | ▮ | ▮ |
| Artios | Drug Discovery | ▮ | ▮ | ▮ |
| Mediar Therapeutics | — | ▮ | ▮ | ▮ |
+ 20 more companies · all 23, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Novartis Venture Fund
- What companies does Novartis Venture Fund invest in?
- Novartis Venture Fund has 23 recorded portfolio companies, including Binx, Artios, Mediar Therapeutics.
- What is Novartis Venture Fund's AUM?
- Novartis Venture Fund manages approximately $750 in assets.